Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

HERG potassium channel and drug trapping: binary QSAR and insights from propafenone derivatives

Andreas Windisch , Evgeny Timin , Steffen Hering , Gerhard Ecker
XXth International Symposium on Medicinal Chemistry (EFMC-ISMC 2008)
Conference, Poster presentation
..2008 - ..2008

Molecular Modelling Studies for analyzing differences in interactions between substrates and inhibitors of the serotonin transporter

Gerhard Ecker , Michael Demel , Marie-Theresa Winkler , Harald H. Sitte
SFB-Symposium 08
Conference, Poster presentation
..2008 - ..2008

Similarity based descriptors for classification of ABCB1 substrates

Gerhard Ecker , Rita Schwaha
17th European Symposium on Quantitative Structure-Activity Relationships & Omics Technologies and Systems Biology
Conference, Poster presentation
..2008 - ..2008

Use your brain - artificial neural networks in drug design

Gerhard Ecker
Talk or oral contribution
7.12.2007 - 7.12.2007

Polyspecific proteins - safety sciences on the molecular level

Gerhard Ecker
Talk or oral contribution
25.10.2007 - 25.10.2007